乐普医疗预计2025年净利润为8亿—12亿元

Group 1 - The core business of cardiovascular interventional products has shown steady revenue growth, while the inventory clearance in the retail channel of the pharmaceutical segment is nearly complete, leading to double-digit revenue growth for Lepu Medical [1] - Lepu Medical forecasts a net profit attributable to shareholders of 800 million to 1.2 billion yuan for 2025, representing a year-on-year growth of 223.97% to 385.95% [3] - The net profit after deducting non-recurring gains and losses is also projected to be between 800 million to 1.2 billion yuan, with a year-on-year increase of 261.29% to 441.93% [3]